Myeloperoxidase impairs mucociliary transport on human airway epithelium
Disease Models & Mechanisms · 01.06.2026 · 19 (6)
DOI: 10.1242/dmm.052764 ↗Kurz gefasst
Fachartikel in der Zeitschrift Disease Models & Mechanisms, online erschienen am 26.05.2026. Verfasst von Allison Boboltz und 3 weiteren Autor:innen. Beteiligte Einrichtung: Fischell Department of Bioengineering, University of Maryland, College Park, MD 20742, USA. Hauptthemen laut MEDLINE: Peroxidase, Mucociliary Clearance, Respiratory Mucosa. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, University of Maryland, Cystic Fibrosis Foundation.
Abstract (Originalsprache)
Dampening neutrophil-driven inflammation in the airways remains a challenge in treating cystic fibrosis (CF) lung disease. Myeloperoxidase (MPO) is a neutrophilic enzyme that produces reactive oxygen species and is highly concentrated in CF airways. Greater MPO concentrations have previously been correlated with increased mucus plugging in bronchiectasis, suggesting that MPO could impair mucociliary transport. As such, we evaluated the impact of MPO treatment on barrier integrity, mucin production, mucus viscoelasticity and mucociliary transport in fully differentiated human airway epithelial cultures at ionic conditions reflective of healthy and CF-affected airways. Using live-cell imaging and particle velocimetry, we found that MPO inhibits mucociliary transport in vitro at CF-like and normal airway conditions. The impairment of mucus clearance by MPO was similar to that by neutrophil elastase, another neutrophilic granular enzyme that damages the host tissues and impairs airway clearance. We also found that subsequent treatment with the reducing agent, N-acetyl cysteine, could alleviate MPO-mediated mucociliary dysfunction through disulfide bond cleavage. These findings identify MPO as a therapeutic target to resolve deficits in airway clearance function in CF and related muco-obstructive lung diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Fischell Department of Bioengineering, University of Maryland, College Park, MD 20742, USA.
- Biological Sciences Graduate Program, University of Maryland, College Park, MD 20742, USA.
ORCID-Profile: Gregg A Duncan
Förderung
- NHLBI NIH HHS
- University of Maryland
- Cystic Fibrosis Foundation
- National Heart, Lung, and Blood Institute
Zitieren
APA
Boboltz, A., Rathi, V., Kumar, S., & Duncan, G. A. (2026). Myeloperoxidase impairs mucociliary transport on human airway epithelium. Disease Models & Mechanisms, 19(6). https://doi.org/10.1242/dmm.052764
Vancouver
Boboltz A, Rathi V, Kumar S, Duncan GA. Myeloperoxidase impairs mucociliary transport on human airway epithelium. Disease Models & Mechanisms. 2026;19(6). doi:10.1242/dmm.052764
BibTeX
@article{Boboltz2026,
author = {Boboltz, Allison and Rathi, Vaidehi and Kumar, Sahana and Duncan, Gregg A},
title = {Myeloperoxidase impairs mucociliary transport on human airway epithelium},
journal = {Disease Models & Mechanisms},
year = {2026},
volume = {19},
number = {6},
doi = {10.1242/dmm.052764}
}
EUVIMED